CC
TCRX icon

Checkpoint Capital’s TScan Therapeutics TCRX Stock Holding History

Checkpoint Capital’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,017,650
Closed -$2.78M – 14
2025
Q1 		$2.78M Buy
2,017,650
+261,663
+15% +$361K 1.53% 10
2024
Q4 		$5.34M Buy
1,755,987
+930,646
+113% +$2.83M 2.72% 9
2024
Q3 		$4.11M Buy
+825,341
New +$4.11M 2.04% 9